AstraZeneca’s coronavirus vaccine suffered a setback that shows why Big Pharma would rather be safe than sorry. Here’s the good news.

2020-09-09

  U.K.-based pharmaceutical giant AstraZeneca said Tuesday it will suspend clinical trials of a coronavirus vaccine it developed with Oxford University after a British subject fell ill. The decision will affect the company’s just-started so-called Phase 3 trial, which recruited 30,000 volunteers in the U.S. after 10,000 subjects in theRead More →

Bad Crypto News of the Week

2020-05-31

It’s been a strange week for BTC as we move forward in our new mining rewards era. The price ends the week down but a late rally has pushed it back over $9,000. Technical analysts expect Bitcoin to continue rising based on the liquidation range of short positions, a discussionRead More →

Gap stock jumps on news it will not spin off Old Navy

2020-01-16

Gap Inc. stock rallied in the extended session Thursday after the retailer backtracked from its plan to spin off its Old Navy brand. Gap GPS, +3.85%  shares rose as much as 9% in after-hours trading after ending the regular trading day up 3.9%. Mounting costs and a softer business performanceRead More →

Asian markets retreat on mixed trade-war news

2019-09-29

Asian markets pulled back in early trading Monday, amid conflicting signals on the trade-war front. China said Sunday that its top trade negotiator, Vice Premier Liu He, will travel to Washington on October for renewed trade negotiations with the U.S. An exact date for the talks was not announced, butRead More →

S&P Comes Back on Trade Hopes, Housing News By Investing.com

2019-09-25

© Reuters. Investing.com – Stocks rebounded from Tuesday’s drubbing after President Donald Trump suggested a trade deal with China might come sooner than anyone thinks and investors seemed inclined to ignore the impeachment threat facing the president. But the rally’s power wasn’t enough to get the S&P 500 above 3,000.Read More →